A synergistically enhanced T(1) -T(2) dual-modal contrast agent.
about
Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imagingGadolinium embedded iron oxide nanoclusters as T1-T2 dual-modal MRI-visible vectors for safe and efficient siRNA deliveryThe art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma.Gd-Al co-doped mesoporous silica nanoparticles loaded with Ru(bpy)₃²⁺ as a dual-modality probe for fluorescence and magnetic resonance imaging.Facile non-hydrothermal synthesis of oligosaccharides coated sub-5 nm magnetic iron oxide nanoparticles with dual MRI contrast enhancement effect.Artificial local magnetic field inhomogeneity enhances T2 relaxivityT1-T2 Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes.Color Tunable Gd-Zn-Cu-In-S/ZnS Quantum Dots for Dual Modality Magnetic Resonance and Fluorescence Imaging.Facile integration of multiple magnetite nanoparticles for theranostics combining efficient MRI and thermal therapy.Geometrically confined ultrasmall gadolinium oxide nanoparticles boost the T(1) contrast ability.Hybrid nanotrimers for dual T1 and T2-weighted magnetic resonance imagingDevelopment of individualized anti-metastasis strategies by engineering nanomedicinesInterplay between longitudinal and transverse contrasts in Fe3O4 nanoplates with (111) exposed surfacesEngineering iodine-doped carbon dots as dual-modal probes for fluorescence and X-ray CT imagingAlbumin-based nanoparticles loaded with hydrophobic gadolinium chelates as T1-T2 dual-mode contrast agents for accurate liver tumor imaging.Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging.Gd-encapsulated carbonaceous dots with efficient renal clearance for magnetic resonance imaging.Active-target T1-weighted MR Imaging of Tiny Hepatic Tumor via RGD Modified Ultra-small Fe3O4 Nanoprobes.Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics.Aptamer-PEG-modified Fe3O4@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cells.Recent advances in magnetic nanoparticle-based multi-modal imaging.Nanomaterial-based activatable imaging probes: from design to biological applications.Syntheses and biomedical applications of hollow micro-/nano-spheres with large-through-holes.Imaging-guided delivery of RNAi for anticancer treatment.Fluorescent/magnetic micro/nano-spheres based on quantum dots and/or magnetic nanoparticles: preparation, properties, and their applications in cancer studies.Designed synthesis and surface engineering strategies of magnetic iron oxide nanoparticles for biomedical applications.The evolution of gadolinium based contrast agents: from single-modality to multi-modality.A high-performance imaging probe with NIR luminescence and synergistically enhanced T1-T2 relaxivity for in vivo hepatic tumor targeting and multimodal imaging.Core/shell Fe3O4/Gd2O3 nanocubes as T1-T2 dual modal MRI contrast agents.Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T(1)-T(2) MRI contrast agents.Europium-engineered iron oxide nanocubes with high T1 and T2 contrast abilities for MRI in living subjects.Biomineral Nano-Theranostic agent for Magnetic Resonance Image Guided, Augmented Radiofrequency Ablation of Liver Tumor.Probing T1-T2 interactions and their imaging implications through a thermally responsive nanoprobe."Smart" theranostic lanthanide nanoprobes with simultaneous up-conversion fluorescence and tunable T1-T2 magnetic resonance imaging contrast and near-infrared activated photodynamic therapy.Sequential growth of CaF2:Yb,Er@CaF2:Gd nanoparticles for efficient magnetic resonance angiography and tumor diagnosis.Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.Deep Photoacoustic/Luminescence/Magnetic Resonance Multimodal Imaging in Living Subjects Using High-Efficiency Upconversion Nanocomposites.Core-Satellite Polydopamine-Gadolinium-Metallofullerene Nanotheranostics for Multimodal Imaging Guided Combination Cancer Therapy.Shape-controlled syntheses of metal oxide nanoparticles by the introduction of rare-earth metals.Gadolinium hybrid iron oxide nanocomposites for dual T1- and T2-weighted MR imaging of cell labeling.
P2860
Q30395463-52547C41-6BDD-460A-8E0E-DEF5F4CF7939Q30657167-CE613973-BEFD-4FC3-90BB-FCEC609475E3Q30809060-F88DCEDE-3E6D-4A28-9C87-BFBE3AC3A060Q30837679-865AF186-F241-45CC-9436-288792F76BFEQ30847182-0EDFFA99-C504-4CE2-933E-D6FA76B5ABACQ30854390-D6EC7391-7B91-46BE-995B-F0AC57FBDE73Q30862611-736150CC-0D44-4997-BB64-605AF67EF552Q30875682-78B91A3E-9A69-4D04-A1AD-C087C952D254Q30884196-AB95EC8B-CABF-4A4E-A2A9-AE64BB8223D1Q31040215-2D1CB36E-4D54-4169-8025-624BA5F3A5F7Q35100728-9BC2F48C-6D02-4E45-A5C5-A9FD30EB593CQ35967474-21324FCD-6B5E-4385-84D2-CF8CBEAF3112Q36057302-90F8E831-68C6-45CE-B3F4-940B135EF76EQ36277953-595F30D1-072D-43CF-AE66-E3EF3A9FF75CQ36314337-02882511-A2E5-4992-991D-4F328E946CC6Q36854172-A6D421A1-C37F-48BB-968C-02DD72903ECEQ36948085-70937B42-F9FC-4CAB-8254-7B7A8B72F917Q37202282-39955AC6-EDE9-421D-8E7E-31F6FEC22CBDQ37404658-6FF136AB-34C7-4CA7-BC76-986632338D99Q37504779-0A43C883-AFB6-44AC-B8CA-1FA608F4D6D9Q38344555-CE2AC9CF-6236-4BA5-8DEC-0A1F467A85D2Q38555053-46B1B77B-9B7E-4506-A319-54940F27E2E3Q38666898-BEF5DDF6-0D83-41A8-BD58-6DC92FB8573EQ38710046-31B4A033-8C93-4D2E-90AA-128EB86E4539Q38718351-349D4A51-3D32-4922-8CAC-A841700C4D9DQ38798699-F62793D6-55C5-45D8-880D-60204499DA45Q38829707-B17D1939-B40B-42AE-8FAB-B088110BA4A5Q38849755-CC6710FB-646F-4B7F-8097-9369165316BCQ38853697-D6C4F153-F0B7-4635-99ED-7BFC64EF119EQ38870993-C3CE902D-00F3-4C71-8350-0A5904885D44Q38895480-9E98FB43-EF5A-4DDC-8CF1-FEF3C2B086CEQ46273981-0EEC8ADE-0175-4E68-8657-4DF22AA988BDQ46327941-1FECE072-586A-48B4-B761-BB736007FDFBQ46843669-98D4F9BD-36B0-4330-8C3D-3FBD066A4D68Q47408271-DD45323B-D417-47CD-8CB3-2E919D8F1197Q47445358-D5408B34-FD2D-4A87-9FC1-0618439A5795Q47710835-ABA88F5F-AE9A-4EF7-BB9A-32E02B1E6F7DQ47929360-9EDB3370-F076-44F5-8344-7F1855A42496Q48197680-A0DE94E6-86E8-4CDD-920C-6E43504DEB3DQ48229636-5D65E2BA-F256-4E50-9683-047C50199EF8
P2860
A synergistically enhanced T(1) -T(2) dual-modal contrast agent.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A synergistically enhanced T(1) -T(2) dual-modal contrast agent.
@ast
A synergistically enhanced T(1) -T(2) dual-modal contrast agent.
@en
type
label
A synergistically enhanced T(1) -T(2) dual-modal contrast agent.
@ast
A synergistically enhanced T(1) -T(2) dual-modal contrast agent.
@en
prefLabel
A synergistically enhanced T(1) -T(2) dual-modal contrast agent.
@ast
A synergistically enhanced T(1) -T(2) dual-modal contrast agent.
@en
P2093
P2860
P356
P1433
P1476
A synergistically enhanced T(1) -T(2) dual-modal contrast agent.
@en
P2093
Dengtong Huang
Jianfeng Bao
Jinhao Gao
Qiaoli Chen
Zhong Chen
Zijian Zhou
P2860
P304
P356
10.1002/ADMA.201203169
P407
P577
2012-09-13T00:00:00Z